NPSP Description — NPS Pharmaceuticals Inc.
NPS Pharmaceuticals is a biopharmaceutical company. Co.'s product, Gattex® 0.05 mg/kg/d (teduglutide [rDNA origin]) is used for the treatment of adult patients with Short Bowel Syndrome (SBS) who are dependent on parenteral support. SBS is a disorder in which the body is unable to absorb enough nutrients and fluids through the gastrointestinal tract. Co.'s second product, Natpara® (rhPTH[1-84]) has been developed for hypoparathyroidism, a multidimensional disorder characterized by deficient or absent parathyroid hormone. Co.'s clinical-stage product candidate is NPSP795, a calcilytic compound with potential application in disorders involving increased calcium receptor activity